Dr. Daniel Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery. He was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK.

Dr Goldberg has 25 years of experience in refractive surgery and has performed over 10,000 LASIK surgery procedures. He recently became the first New Jersey eye surgeon to use the implantable contact lens (ICL) - a new technology to correct nearsightedness in individuals with extremely high prescriptions.

In 2008, Dr Goldberg was also recently honored by Castle Connolly Medical who presented him with their annual ‘Top Doctor" award which recognizes him as one of the best doctors in the field of Ophthalmology. Then, in April of 2008, Dr Goldberg was again recognized at the inaugural training session for Custom Vue Monovision in Chicago for helping to set the stage for the FDA approval of LASIK monovision.

Dr Goldberg is constantly on the forefront of groundbreaking technology and innovations in the field of Ophthalmology. Currently Dr Goldberg is leading a worldwide study testing the effectiveness of using 5% Betadine irrigation for the treatment of acute EKC- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement. Ophthalmologists around the world are invited to register to participate in the Betadine for EKC study and can do so by visiting http://www.betadineforekc.com/submission-process.aspx.

More information on Dr Daniel Goldberg is available at http://www.refractivesurgerynj.com/